Literature DB >> 28768154

Binding effect of fluorescence labeled glycyrrhetinic acid with GA receptors in hepatocellular carcinoma cells.

Yu-Qi Sun1, Chun-Mei Dai2, Yan Zheng2, Shu-Dan Shi2, Hai-Yang Hu3, Da-Wei Chen4.   

Abstract

Glycyrrhetinic acid (GA) is a natural active component from licorice, which is broadly used in traditional Chinese medicine. Lots of glycyrrhetinic acid receptors (GA-R) are proved to locate on the surface of liver cells. Many reports about the hepatocellular carcinoma (HCC) treatment were dependent on GA modified carriers. However, the reality of GA-R in HCC cells was not clear. In this paper, 18β-glycyrrhetinic acid (18β-GA) was labeled with fluorescence (FITC) by chemical synthesis. Together with the binding effect of fluorescence labeled glycyrrhetinic acid (FITC-GA), the competitive action of 18β-GA with GA-R was investigated in HCC cells. The results showed that in HepG2 cells, 18β-GA and FITC-GA presented similar cytotoxicity. The specific binding saturation of GA showed the dissociation constant (Kd) was 7.457±2.122pmol/L and the maximum binding counts (Bmax) was 2.385±0.175pmol/2.5×106 cells, respectively. FITC-GA bound to cytomembrane specifically and 18β-GA competed to bind the sites significantly in HepG2 cells. Therefore, there is binding effect between fluorescence labeled GA and GA-R. The GA-R on HCC cells is confirmed as expected, which provides a useful reference of active target modified by GA and a novel approach for receptors and ligands study.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Glycyrrhetinic acid; fluorescence labeled; receptor saturation; completive effect; hepatocellular carcinoma cells.

Mesh:

Substances:

Year:  2017        PMID: 28768154     DOI: 10.1016/j.lfs.2017.07.032

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  6 in total

Review 1.  Research progress on the protective effects of licorice-derived 18β-glycyrrhetinic acid against liver injury.

Authors:  Shou-Yan Wu; Wen-Jie Wang; Jin-Hui Dou; Li-Kun Gong
Journal:  Acta Pharmacol Sin       Date:  2020-03-06       Impact factor: 6.150

2.  Development of dual-targeted nano-dandelion based on an oligomeric hyaluronic acid polymer targeting tumor-associated macrophages for combination therapy of non-small cell lung cancer.

Authors:  Bingjie Wang; Wei Zhang; Xiudi Zhou; Mengna Liu; Xiaoya Hou; Ziting Cheng; Daquan Chen
Journal:  Drug Deliv       Date:  2019-12       Impact factor: 6.419

Review 3.  Cancer nanotechnology: Enhancing tumor cell response to chemotherapy for hepatocellular carcinoma therapy.

Authors:  Yongbing Sun; Wen Ma; Yuanyuan Yang; Mengxue He; Aimin Li; Lei Bai; Bin Yu; Zhiqiang Yu
Journal:  Asian J Pharm Sci       Date:  2019-06-12       Impact factor: 6.598

Review 4.  Smart Responsive Nanoformulation for Targeted Delivery of Active Compounds From Traditional Chinese Medicine.

Authors:  Xuejun Jiang; Mei Lin; Jianwen Huang; Mulan Mo; Houhe Liu; Yuan Jiang; Xiaowen Cai; Wingnang Leung; Chuanshan Xu
Journal:  Front Chem       Date:  2020-12-10       Impact factor: 5.221

5.  A nano-preparation approach to enable the delivery of daphnoretin to potentiate the therapeutical efficacy in hepatocellular cancer.

Authors:  Guanglin Zhu; Bing Wang; Guo Feng; Zhirong Zhou; Wei Li; Wen Liu; Hongmei Su; Wenjing Wang; Tiejie Wang; Xie-An Yu
Journal:  Front Pharmacol       Date:  2022-09-28       Impact factor: 5.988

6.  Hepatocellular carcinoma-targeted effect of configurations and groups of glycyrrhetinic acid by evaluation of its derivative-modified liposomes.

Authors:  Yuqi Sun; Chunmei Dai; Meilin Yin; Jinghua Lu; Haiyang Hu; Dawei Chen
Journal:  Int J Nanomedicine       Date:  2018-03-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.